Targeting an IKBKE cytokine network impairs triple-negative breast cancer growthThanh U. Barbie, William E. Gillanders, Gabriela Alexe et al.|Journal of Clinical Investigation|2014Cited by 154
EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancerSavas D. Soysal, W.E. Gillanders, Simone Muenst et al.|British Journal of Cancer|2013Cited by 140
Supplementary Table 3 from Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor ImmunityXiuli Zhang, William E. Gillanders, Samuel Kim et al.|Unknown|2023Cited by 0
Supplementary Table 3 from Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor ImmunityXiuli Zhang, William E. Gillanders, Samuel Kim et al.|Unknown|2023Cited by 0
Supplementary Table 2 from Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor ImmunityXiuli Zhang, William E. Gillanders, Samuel Kim et al.|Unknown|2023Cited by 0